Interferon- (IFN) neurotoxicity
Assess for acute severe complications, e.g., hyperviscosity syndrome, stroke or pulmonary embolus
Abstract Synthetic biology has emerged as a rapidly advancing field, with its promising applications in human health attracting increasing attention
By adding change in body weight after 5 weeks of treatment as a covariate to the statistical model in a post hoc analysis, the treatment-related differences in 24-h EE as described above were reduced (2%, P =0.21 and 3%, P =0.02 for liraglutide 1.8 mg and 3.0 mg versus placebo, respectively
Clinical Applications and Target Markets Liposomal nad powder is used in many therapeutic situations where better bioavailability is a measured benefit
doi:10.1097/PRS.0000000000009876